Moreover, frequent amplification of the RUNX2 gene in osteosarcoma cell lines correlates with elevated RUNX2 levels, subsequently initiating MYC transcription and driving osteosarcoma tumorigenesis and progression [63]. This evidence concerns the gene MYC and osteosarcoma.